Kamal M, Baudo M, Joseph J, Geng Y, Mohamed O, Rahouma M
Healthcare (Basel). 2024; 12(5).
PMID: 38470640
PMC: 10931059.
DOI: 10.3390/healthcare12050530.
Nagasaka H, Takebe S, Yamamoto S, Kondo T, Terao H, Nakaigawa N
Case Rep Oncol. 2023; 16(1):1028-1032.
PMID: 37900855
PMC: 10601775.
DOI: 10.1159/000533888.
Massimino M, Iaquinta F, Naty S, Andreozzi F, Grembiale R
Medicina (Kaunas). 2023; 59(7).
PMID: 37512160
PMC: 10384992.
DOI: 10.3390/medicina59071349.
Anpalakhan S, Huddar P, Behrouzi R, Signori A, Cave J, Comins C
Int J Mol Sci. 2023; 24(2).
PMID: 36675262
PMC: 9867035.
DOI: 10.3390/ijms24021746.
Hasanvand A
Inflammopharmacology. 2022; 30(3):789-798.
PMID: 35505267
PMC: 9064717.
DOI: 10.1007/s10787-022-00992-2.
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.
Buske C, Dreyling M, Alvarez-Larran A, Apperley J, Arcaini L, Besson C
ESMO Open. 2022; 7(2):100403.
PMID: 35272130
PMC: 8795783.
DOI: 10.1016/j.esmoop.2022.100403.
COVID 19 and febrile neutropenia: Case report and systematic review.
Kaya T, Dilek A, Ozaras R, Balcik O, Leblebicioglu H
Travel Med Infect Dis. 2022; 47:102305.
PMID: 35272019
PMC: 8901240.
DOI: 10.1016/j.tmaid.2022.102305.
COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response.
Gur I, Giladi A, Isenberg Y, Neuberger A, Stern A
Acta Haematol. 2022; 145(3):297-309.
PMID: 35235928
PMC: 9254311.
DOI: 10.1159/000523872.
Severe Post-COVID-19 Organizing Pneumonia during Cancer Immunochemotherapy.
Kitahara A, Ebihara A, Obayashi S, Horio Y, Ono Y, Yoshikawa T
Intern Med. 2022; 61(8):1219-1223.
PMID: 35135922
PMC: 9107986.
DOI: 10.2169/internalmedicine.8928-21.
Acute respiratory distress syndrome precipitated by granulocyte colony-stimulating factor in undiagnosed pneumonia.
Doig C, Cooke R, Chua C, Leung T
BMJ Case Rep. 2022; 15(2).
PMID: 35115328
PMC: 8814741.
DOI: 10.1136/bcr-2021-242316.
A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis.
Sereno M, Jimenez-Gordo A, Baena-Espinar J, Aguado C, Mielgo X, Pertejo A
Cancers (Basel). 2021; 13(16).
PMID: 34439359
PMC: 8391975.
DOI: 10.3390/cancers13164205.
Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic.
Mukherji R, Marshall J
Curr Treat Options Oncol. 2021; 22(10):93.
PMID: 34424418
PMC: 8381863.
DOI: 10.1007/s11864-021-00888-3.
Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era.
Lyman G, Kuderer N, Aapro M
Front Oncol. 2021; 11:697908.
PMID: 34307165
PMC: 8299941.
DOI: 10.3389/fonc.2021.697908.
Prolonged Self-Resolving Neutropenia Following Asymptomatic COVID-19 Infection.
Desai S, Quraishi J, Citrin D
Cureus. 2021; 13(7):e16451.
PMID: 34290941
PMC: 8287839.
DOI: 10.7759/cureus.16451.
Neutrophils at the crossroads of acute viral infections and severity.
Rawat S, Vrati S, Banerjee A
Mol Aspects Med. 2021; 81:100996.
PMID: 34284874
PMC: 8286244.
DOI: 10.1016/j.mam.2021.100996.
Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.
Stahl M, Narendra V, Jee J, Derkach A, Maloy M, Geyer M
Leuk Lymphoma. 2021; 62(8):1940-1948.
PMID: 34180767
PMC: 10080398.
DOI: 10.1080/10428194.2021.1885664.
Preinfection laboratory parameters may predict COVID-19 severity in tumor patients.
Kiani A, Roesch R, Wendtner C, Kullmann F, Kubin T, Sudhoff T
Cancer Med. 2021; 10(13):4424-4436.
PMID: 34121360
PMC: 8267142.
DOI: 10.1002/cam4.4023.
The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection.
Zhang A, Morjaria S, Kaltsas A, Hohl T, Parameswaran R, Patel D
Clin Infect Dis. 2021; 74(4):567-574.
PMID: 34111237
PMC: 8406899.
DOI: 10.1093/cid/ciab534.
COVID-19 in a patient receiving adjuvant breast cancer chemotherapy with granulocyte olony-stimulating factor (G-CSF) support: A case report.
Yerushalmi R, Sagi M, Goldvaser H, Daliot J, Mutai R, Krause I
Mol Clin Oncol. 2021; 14(6):117.
PMID: 33903823
PMC: 8060854.
DOI: 10.3892/mco.2021.2279.
G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation.
Karagiannidis I, Salataj E, Egal E, Beswick E
Cytokine. 2021; 142:155479.
PMID: 33677228
PMC: 8044051.
DOI: 10.1016/j.cyto.2021.155479.
